Edesa Biotech Inc. (NASDAQ: EDSA)
$4.80
+0.5600 ( +13.21% ) 28.5K
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Market Data
Open
$4.80
Previous close
$4.24
Volume
28.5K
Market cap
$15.34M
Day range
$4.19 - $4.97
52 week range
$2.46 - $8.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 17 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
8-k | 8K-related | 16 | May 30, 2024 |
8-k | 8K-related | 17 | May 10, 2024 |
10-q | Quarterly Reports | 62 | May 10, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
ars | Annual reports | 104 | Apr 05, 2024 |
def | Proxies and info statements | 3 | Apr 05, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |